Angiotensin-(1-7): Beyond the cardio-renal actions

Clinical Science

Volumn 124, Issue 7, 2013, Pages 443-456

  Passos Silva, Danielle G ^a   Verano Braga, Thiago ^a,b   Santos, Robson A S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Angiotensin (1 7); Angiotensin converting enayme 2 (ACE2); Mas receptor; Renin angiotensin system (RAS)

Indexed keywords

ANGIOTENSIN[1-7]; GLUCOSE; LIPID;

ANGIOGENESIS; BRAIN PROTECTION; CELL PROLIFERATION; DRUG MECHANISM; FIBROSIS; GLUCOSE METABOLISM; HEART PROTECTION; HORMONE ACTION; HUMAN; INFLAMMATION; LEARNING; LIPID METABOLISM; MEMORY; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCTION; REVIEW; SPERMATOGENESIS; STEROIDOGENESIS;

ANGIOGENESIS INHIBITORS; ANGIOTENSIN I; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BRAIN ISCHEMIA; CELL PROLIFERATION; FEMALE; FIBROSIS; GLUCOSE; HUMANS; INSULIN; KIDNEY; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84872227553     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120461     Document Type: Review

References (145)

1. Schiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C. and Ferrario, C. M. (1988) Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc. Natl. Acad. Sci. U.S.A. 85, 4095-4098
2. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M., Mendes, E. P., Lemos, V. S., Campagnole-Santos, M. J., Schultheiss, H. P., Speth, R. and Walther, T. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263
3. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R. E. and Acton, S. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
4. Nguyen, G., Delarue, F., Berrou, J., Rondeau, E. and Sraer, J. D. (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50, 1897-1903
5. Ferrario, C. M. (2011) ACE2: more of Ang-(1-7) or less Ang II? Curr. Opin. Nephrol. Hypertens. 20, 1-6
6. Rabelo, L. A., Alenina, N. and Bader, M. (2011) ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens. Res. 34, 154-160
7. Ferreira, A. J. and Santos, R. A. (2005) Cardiovascular actions of angiotensin-(1-7). Braz. J. Med. Biol. Res. 38, 499-507
8. Ferrario, C. M. and Varagic, J. (2010) The Ang-(1-7)/ACE2/mas axis in the regulation of nephron function. Am. J. Physiol. Renal. Physiol. 298, F1297-F1305
9. Bader, M. (2007) The second life of the (pro)renin receptor. JRAAS 8, 205-208
10. Ocaranza, M. P. and Jalil, J. E. (2012) Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling. Int. J. Hypertens. 2012, 594361
11. Flores-Munoz, M., Work, L. M., Douglas, K., Denby, L., Dominiczak, A. F., Graham, D. and Nicklin, S. A. (2012) Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension 59, 300-307
12. Ferrario, C. M. and Iyer, S. N. (1998) Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul. Pept. 78, 13-18
13. Rice, G. I., Thomas, D. A., Grant, P. J., Turner, A. J. and Hooper, N. M. (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 383, 45-51
14. Iwata, M., Cowling, R. T., Yeo, S. J. and Greenberg, B. (2011) Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure. J. Mol. Cell. Cardiol. 51, 542-547
15. Tikellis, C., Bernardi, S. and Burns, W. C. (2011) Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 20, 62-68
16. Castro-Chaves, P., Cerqueira, R., Pintalhao, M. and Leite-Moreira, A. F. (2010) New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert Opin. Ther. Targets 14, 485-496
17. Leung, P. S., Chan, H. C., Fu, L. X. and Wong, P. Y. (1997) Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J. Endocrinol. 153, 269-274
18. Leung, P. S., Chan, W. P., Wong, T. P. and Sernia, C. (1999) Expression and localization of the renin-angiotensin system in the rat pancreas. J. Endocrinol. 160, 13-19
19. Schling, P., Mallow, H., Trindl, A. and Loffler, G. (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int. J. Obes. Relat. Metab. Disord. 23, 336-341
20. Lupi, R., Del Guerra, S., Bugliani, M., Boggi, U., Mosca, F., Torri, S., Del Prato, S. and Marchetti, P. (2006) The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur. J. Endocrinol. 154, 355-361
21. Gupte, M., Boustany-Kari, C. M., Bharadwaj, K., Police, S., Thatcher, S., Gong, M. C., English, V. L. and Cassis, L. A. (2008) ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R781-R788
22. Coelho, M. S., Lopes, K. L., Freitas Rde, A., de Oliveira-Sales, E. B., Bergasmaschi, C. T., Campos, R. R., Casarini, D. E., Carmona, A. K., Araujo Mda, S., Heimann, J. C. and Dolnikoff, M. S. (2010) High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. Regul. Pept. 162, 61-67
23. Grundy, S. M., Brewer, Jr, H. B., Cleeman, J. I., Smith, Jr, S. C. and Lenfant, C. (2004) Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438
24. Reaven, G. M. (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607
25. Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmaki, K., Dahlof, B., de Faire, U., Morlin, C. et al. (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611-616
26. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H. H., Remuzzi, G., Snapinn, S. M., Zhang, Z. and Shahinfar, S. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869
27. Yusuf, S., Gerstein, H., Hoogwerf, B., Pogue, J., Bosch, J., Wolffenbuttel, B. H. and Zinman, B. (2001) Ramipril and the development of diabetes. JAMA, J. Am. Med. Assoc. 286, 1882-1885
28. Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O. et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995-1003
29. Oliveira, M. A., Carvalho, M. H., Nigro, D., Passaglia Rde, C. and Fortes, Z. B. (2002) Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study. Peptides 23, 1449-1455
30. Furuhashi, M., Ura, N., Takizawa, H., Yoshida, D., Moniwa, N., Murakami, H., Higashiura, K. and Shimamoto, K. (2004) Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J. Hypertens. 22, 1977-1982
31. Giani, J. F., Mayer, M. A., Munoz, M. C., Silberman, E. A., Hocht, C., Taira, C. A., Gironacci, M. M., Turyn, D. and Dominici, F. P. (2009) Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am. J. Physiol. Endocrinol. Metab. 296, E262-E271
32. Singh, K., Singh, T. and Sharma, P. L. (2011) Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy. Ther. Adv. Cardiovasc. Dis. 5, 159-167
33. Bindom, S. M., Hans, C. P., Xia, H., Boulares, A. H. and Lazartigues, E. (2010) Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 59, 2540-2548
34. Santos, S. H., Fernandes, L. R., Mario, E. G., Ferreira, A. V., Porto, L. C., Alvarez-Leite, J. I., Botion, L. M., Bader, M., Alenina, N. and Santos, R. A. (2008) Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57, 340-347
35. Liu, C., Lv, X. H., Li, H. X., Cao, X., Zhang, F., Wang, L., Yu, M. and Yang, J. K. (2011) Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 49, 291-299
36. Beard, K. M., Lu, H., Ho, K. and Fantus, I. G. (2006) Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 55, 2678-2687
37. Henriksen, E. J., Jacob, S., Augustin, H. J. and Dietze, G. J. (1996) Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes 45 (Suppl. 1), S125-S128
38. Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49, 185-192
39. Giani, J. F., Gironacci, M. M., Munoz, M. C., Pena, C., Turyn, D. and Dominici, F. P. (2007) Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am. J. Physiol. Heart. Circ. Physiol. 293, H1154-H1163
40. Sampaio, W. O., Henrique de Castro, C., Santos, R. A., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50, 1093-1098
41. Munoz, M. C., Giani, J. F., Burghi, V., Mayer, M. A., Carranza, A., Taira, C. A. and Dominici, F. P. (2012) The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul. Pept. 177, 1-11
42. Verano-Braga, T., Schwammle, V., Sylvester, M., Passos-Silva, D. G., Peluso, A. A., Etelvino, G. M., Santos, R. A. and Roepstorff, P. (2012) Time-resolved quantitative phosphoproteomics: new insights into angiotensin-(1-7) signaling networks in human endothelial cells. J. Proteome Res. 11, 3370-3381
43. Alessi, D. R., and jelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B. A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551
44. Bellacosa, A., Chan, T. O., Ahmed, N. N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J. and Tsichlis, P. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313-325
45. Munoz, M. C., Giani, J. F. and Dominici, F. P. (2010) Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul. Pept. 161, 1-7
46. Domin, J., Pages, F., Volinia, S., Rittenhouse, S. E., Zvelebil, M. J., Stein, R. C. and Waterfield, M. D. (1997) Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326, 139-147
47. Falasca, M., Hughes, W. E., Dominguez, V., Sala, G., Fostira, F., Fang, M. Q., Cazzolli, R., Shepherd, P. R., James, D. E. and Maffucci, T. (2007) The role of phosphoinositide 3-kinase C2alpha in insulin signaling. J. Biol. Chem. 282, 28226-28236
48. Kovacina, K. S., Park, G. Y., Bae, S. S., Guzzetta, A. W., Schaefer, E., Birnbaum, M. J. and Roth, R. A. (2003) Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J. Biol. Chem. 278, 10189-10194
49. Vander Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J. and Kim, D. H. (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323
50. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
51. Nakashima, K., Yakabe, Y., Yamazaki, M. and Abe, H. (2006) Effects of fasting and refeeding on expression of atrogin-1 and Akt/FOXO signaling pathway in skeletal muscle of chicks. Biosci. Biotechnol. Biochem. 70, 2775-2778
52. Singh, T., Singh, K. and Sharma, P. L. (2010) Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats. Methods Find. Exp. Clin. Pharmacol. 32, 19-25
53. Santos, S. H., Braga, J. F., Mario, E. G., Porto, L. C., Rodrigues-Machado Mda, G., Murari, A., Botion, L. M., Alenina, N., Bader, M. and Santos, R. A. (2010) Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler. Thromb. Vasc. Biol. 30, 953-961
54. Jayasooriya, A. P., Mathai, M. L., Walker, L. L., Begg, D. P., Denton, D. A., Cameron-Smith, D., Egan, G. F., McKinley, M. J., Rodger, P. D., Sinclair, A. J. et al. (2008) Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc. Natl. Acad. Sci. U.S.A. 105, 6531-6536
55. Mario, E. G., Santos, S. H., Ferreira, A. V., Bader, M., Santos, R. A. and Botion, L. M. (2012) Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor γ expression in adipocytes. Peptides 33, 174-177
56. Sharma, A. M. and Staels, B. (2007) Review: Peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92, 386-395
57. Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A. and Kurtz, T. W. (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43, 993-1002
58. Oh, Y. B., Kim, J. H., Park, B. M., Park, B. H. and Kim, S. H. (2012) Captopril intake decreases body weight gain via angiotensin-(1-7). Peptides 37, 79-85
59. Gallagher, P. E. and Tallant, E. A. (2004) Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25, 2045-2052
60. Menon, J., Soto-Pantoja, D. R., Callahan, M. F., Cline, J. M., Ferrario, C. M., Tallant, E. A. and Gallagher, P. E. (2007) Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 67, 2809-2815
61. Cook, K. L., Metheny-Barlow, L. J., Tallant, E. A. and Gallagher, P. E. (2010) Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cancer Res. 70, 8319-8328
62. Calnan, D. R. and Brunet, A. (2008) The FoxO code. Oncogene 27, 2276-2288
63. Oellerich, M. F. and Potente, M. (2012) FOXOs and sirtuins in vascular growth, maintenance and aging. Circ. Res. 110, 1238-1251
64. Xu, K., Chong, D. C., Rankin, S. A., Zorn, A. M. and Cleaver, O. (2009) Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev. Biol. 329, 269-279
65. Machado, R. D., Santos, R. A. and Andrade, S. P. (2001) Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R994-R1000
66. Anton, L., Merrill, D. C., Neves, L. A. and Brosnihan, K. B. (2007) Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 32, 212-218
67. Soto-Pantoja, D. R., Menon, J., Gallagher, P. E. and Tallant, E. A. (2009) Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol. Cancer. Ther. 8, 1676-1683
68. Krishnan, B., Torti, F. M., Gallagher, P. E. and Tallant, E. A. (2012) Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. Prostate, doi:10.1002/pros.22540
69. Petty, W. J., Miller, A. A., McCoy, T. P., Gallagher, P. E., Tallant, E. A. and Torti, F. M. (2009) Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clin. Cancer Res. 15, 7398-7404
70. Krishnan, B., Smith, T. L., Dubey, P., Zapadka, M. E., Torti, F. M., Willingham, M. C., Tallant, E. A. and Gallagher, P. E. (2012) Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate, doi:10.1002/pros.22542
71. Ni, L., Feng, Y., Wan, H., Ma, Q., Fan, L., Qian, Y., Li, Q., Xiang, Y. and Gao, B. (2012) Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol. Rep. 27, 783-790
72. Pereira, V. M., Reis, F. M., Santos, R. A., Cassali, G. D., Santos, S. H., Honorato-Sampaio, K. and dos Reis, A. M. (2009) Gonadotropin stimulation increases the expression of angiotensin-(1-7) and MAS receptor in the rat ovary. Reprod. Sci. 16, 1165-1174
73. Reis, F. M., Bouissou, D. R., Pereira, V. M., Camargos, A. F., dos Reis, A. M. and Santos, R. A. (2011) Angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil. Steril. 95, 176-181
74. Vaz-Silva, J., Carneiro, M. M., Ferreira, M. C., Pinheiro, S. V., Silva, D. A., Silva-Filho, A. L., Witz, C. A., Reis, A. M., Santos, R. A. and Reis, F. M. (2009) The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reprod. Sci. 16, 247-256
75. Pringle, K. G., Tadros, M. A., Callister, R. J. and Lumbers, E. R. (2011) The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta 32, 956-962
76. Costa, A. P., Fagundes-Moura, C. R., Pereira, V. M., Silva, L. F., Vieira, M. A., Santos, R. A. and Dos Reis, A. M. (2003) Angiotensin-(1-7): a novel peptide in the ovary. Endocrinology 144, 1942-1948
77. Shah, D. M., Higuchi, K., Inagami, T. and Osteen, K. G. (1991) Effect of progesterone on renin secretion in endometrial stromal, chorionic trophoblast and mesenchymal monolayer cultures. Am. J. Obstet. Gynecol. 164, 1145-1150
78. Leal, M. C., Pinheiro, S. V., Ferreira, A. J., Santos, R. A., Bordoni, L. S., Alenina, N., Bader, M. and Franca, L. R. (2009) The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats. J. Anat. 214, 736-743
79. Araki-Taguchi, M., Nomura, S., Ino, K., Sumigama, S., Yamamoto, E., Kotani-Ito, T., Hayakawa, H., Kajiyama, H., Shibata, K., Itakura, A. and Kikkawa, F. (2008) Angiotensin II mimics the hypoxic effect on regulating trophoblast proliferation and differentiation in human placental explant cultures. Life Sci. 82, 59-67
80. Xia, Y., Wen, H. Y. and Kellems, R. E. (2002) Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation. J. Biol. Chem. 277, 24601-24608
81. Tonellotto dos Santos, J., Ferreira, R., Gasperin, B. G., Siqueira, L. C., de Oliveira, J. F., Santos, R. A., Reis, A. M. and Goncalves, P. B. (2012) Molecular characterization and regulation of the angiotensin-converting enzyme type 2/angiotensin-(1-7)/MAS receptor axis during the ovulation process in cattle. JRAAS 13, 91-98
82. Goncalves, P. B., Ferreira, R., Gasperin, B. and Oliveira, J. F. (2012) Role of angiotensin in ovarian follicular development and ovulation in mammals: a review of recent advances. Reproduction 143, 11-20
83. Honorato-Sampaio, K., Pereira, V. M., Santos, R. A. and Reis, A. M. (2012) Evidence that angiotensin-(1-7) is an intermediate of gonadotrophin-induced oocyte maturation in the rat preovulatory follicle. Exp. Physiol. 97, 642-650
84. Brosnihan, K. B., Bharadwaj, M. S., Yamaleyeva, L. M. and Neves, L. A. (2012) Decidualized pseudopregnant rat uterus shows marked reduction in Ang II and Ang-(1-7) levels. Placenta 33, 17-23
85. Vaz-Silva, J., Tavares, R. L., Ferreira, M. C., Honorato-Sampaio, K., Cavallo, I. K., Santos, R. A., Dos Reis, A. M. and Reis, F. M. (2012) Tissue specific localization of angiotensin-(1-7) and its receptor Mas in the uterus of ovariectomized rats. J. Mol. Histol. 43, 597-602
86. Neves, L. A., Stovall, K., Joyner, J., Valdes, G., Gallagher, P. E., Ferrario, C. M., Merrill, D. C. and Brosnihan, K. B. (2008) ACE2 and Ang-(1-7) in the rat uterus during early and late gestation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R151-R161
87. Velloso, E. P., Vieira, R., Cabral, A. C., Kalapothakis, E. and Santos, R. A. (2007) Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype. Braz. J. Med. Biol. Res. 40, 583-590
88. Anton, L., Merrill, D. C., Neves, L. A., Stovall, K., Gallagher, P. E., Diz, D. I., Moorefield, C., Gruver, C., Ferrario, C. M. and Brosnihan, K. B. (2008) Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 51, 1066-1072
89. Pandey, K. N., Maki, M. and Inagami, T. (1984) Detection of renin mRNA in mouse testis by hybridization with renin cDNA probe. Biochem. Biophys. Res. Commun. 125, 662-667
90. Deschepper, C. F., Mellon, S. H., Cumin, F., Baxter, J. D. and Ganong, W. F. (1986) Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal and pituitary of the rat. Proc. Natl. Acad. Sci. U.S.A. 83, 7552-7556
91. Metzger, R., Bader, M., Ludwig, T., Berberich, C., Bunnemann, B. and Ganten, D. (1995) Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 357, 27-32
92. Alenina, N., Baranova, T., Smirnow, E., Bader, M., Lippoldt, A., Patkin, E. and Walther, T. (2002) Cell type-specific expression of the Mas proto-oncogene in testis. J. Histochem. Cytochem. 50, 691-696
93. Reis, A. B., Araujo, F. C., Pereira, V. M., Dos Reis, A. M., Santos, R. A. and Reis, F. M. (2010) Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility. J. Mol. Histol. 41, 75-80
94. Walther, T., Balschun, D., Voigt, J. P., Fink, H., Zuschratter, W., Birchmeier, C., Ganten, D. and Bader, M. (1998) Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J. Biol. Chem. 273, 11867-11873
95. Ghosh, A. K. and Vaughan, D. E. (2012) Fibrosis: is it a coactivator disease? Front. Biosci. 4, 1556-1570
96. Krenning, G., Zeisberg, E. M. and Kalluri, R. (2010) The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 225, 631-637
97. Wang, K., Hu, X., Du, C., Tu, S., Zhang, F. and Xie, X. (2012) Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression. Mol. Cell. Biochem. 365, 19-27
98. Oudit, G. Y. and Penninger, J. M. (2011) Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy. Curr. Heart Failure Rep. 8, 176-183
99. Santos, R. A., Castro, C. H., Gava, E., Pinheiro, S. V., Almeida, A. P., Paula, R. D., Cruz, J. S., Ramos, A. S., Rosa, K. T., Irigoyen, M. C. et al. (2006) Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension 47, 996-1002
100. Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X. H., Penninger, J. M., Kassiri, Z. and Oudit, G. Y. (2010) Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and cardiac dysfunction. Circulation 122, 717-728
101. Lubel, J. S., Herath, C. B., Tchongue, J., Grace, J., Jia, Z., Spencer, K., Casley, D., Crowley, P., Sievert, W., Burrell, L. M. and Angus, P. W. (2009) Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin. Sci. 117, 375-386
102. Pereira, R. M., Dos Santos, R. A., Teixeira, M. M., Leite, V. H., Costa, L. P., da Costa Dias, F. L., Barcelos, L. S., Collares, G. B. and Simoes e Silva, A. C. (2007) The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J. Hepatol. 46, 674-681
103. Osterreicher, C. H., Taura, K., De Minicis, S., Seki, E., Penz-Osterreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M. and Brenner, D. A. (2009) Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 50, 929-938
104. Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M. and Angus, P. W. (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54, 1790-1796
105. Herath, C. B., Warner, F. J., Lubel, J. S., Dean, R. G., Jia, Z., Lew, R. A., Smith, A. I., Burrell, L. M. and Angus, P. W. (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J. Hepatol. 47, 387-395
106. Shenoy, V., Ferreira, A. J., Qi, Y., Fraga-Silva, R. A., Diez-Freire, C., Dooies, A., Jun, J. Y., Sriramula, S., Mariappan, N., Pourang, D. et al. (2010) The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 182, 1065-1072
107. Uhal, B. D., Li, X., Xue, A., Gao, X. and Abdul-Hafez, A. (2011) Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L269-L274
108. Ruiz-Ortega, M., Esteban, V., Ruperez, M., Sanchez-Lopez, E., Rodriguez-Vita, J., Carvajal, G. and Egido, J. (2006) Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr. Opin. Nephrol. Hypertens. 15, 159-166
109. Ruiz-Ortega, M., Ruperez, M., Esteban, V., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G. and Egido, J. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20
110. Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V. and Egido, J. (2003) Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881-900
111. Marchesi, C., Paradis, P. and Schiffrin, E. L. (2008) Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 29, 367-374
112. Souza, L. L. and Costa-Neto, C. M. (2012) Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. J. Cell. Physiol. 227, 2117-2122
113. da Silveira, K. D., Coelho, F. M., Vieira, A. T., Sachs, D., Barroso, L. C., Costa, V. V., Bretas, T. L., Bader, M., de Sousa, L. P., da Silva, T. A. et al. (2010) Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J. Immunol. 185, 5569-5576
114. Corrado, E., Rizzo, M., Coppola, G., Fattouch, K., Novo, G., Marturana, I., Ferrara, F. and Novo, S. (2010) An update on the role of markers of inflammation in atherosclerosis. J. Atheroscler. Thromb. 17, 1-11
115. Tesanovic, S., Vinh, A., Gaspari, T. A., Casley, D. and Widdop, R. E. (2010) Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30, 1606-1613
116. Jawien, J., Toton-Zuranska, J., Gajda, M., Niepsuj, A., Gebska, A., Kus, K., Suski, M., Pyka-Fosciak, G., Nowak, B., Guzik, T. J. et al. (2012) Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J. Physiol. Pharmacol. 63, 77-85
117. Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P. C., Levitt, K. S., Oudit, G. Y., Al-Omran, M., Stewart, D. J. et al. (2008) Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Heart. Circ. Physiol. 295, H1377-H1384
118. Dong, B., Zhang, C., Feng, J. B., Zhao, Y. X., Li, S. Y., Yang, Y. P., Dong, Q. L., Deng, B. P., Zhu, L., Yu, Q. T. et al. (2008) Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28, 1270-1276
119. El-Hashim, A. Z., Renno, W. M., Raghupathy, R., Abduo, H. T., Akhtar, S. and Benter, I. F. (2012) Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways. Br. J. Pharmacol. 166, 1964-1976
120. Wosten-van Asperen, R. M., Lutter, R., Specht, P. A., Moll, G. N., van Woensel, J. B., van der Loos, C. M., van Goor, H., Kamilic, J., Florquin, S. and Bos, A. P. (2011) Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 225, 618-627
121. Esteban, V., Heringer-Walther, S., Sterner-Kock, A., de Bruin, R., van den Engel, S., Wang, Y., Mezzano, S., Egido, J., Schultheiss, H. P., Ruiz-Ortega, M. and Walther, T. (2009) Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS ONE 4, e5406
122. Zimmerman, D. and Burns, K. D. (2012) Angiotensin-(1-7) in kidney disease: a review of the controversies. Clin. Sci. 123, 333-346
123. Becker, L. K., Etelvino, G. M., Walther, T., Santos, R. A. and Campagnole-Santos, M. J. (2007) Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am. J. Physiol. Heart Circ. Physiol. 293, H1416-H1424
124. Campagnole-Santos, M. J., Heringer, S. B., Batista, E. N., Khosla, M. C. and Santos, R. A. (1992) Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am. J. Physiol. 263, R89-R94
125. Xu, P., Sriramula, S. and Lazartigues, E. (2011) ACE2/Ang-(1-7)/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R804-R817
126. Holy, Z., Braszko, J., Kupryszewski, G., Witczuk, B. and Wisniewski, K. (1992) Angiotensin II-derived peptides devoid of phenylalanine in position 8 have full psychotropic activity of the parent hormone. J. Physiol. Pharmacol. 43, 183-192
127. Lazaroni, T. L., Raslan, A. C., Fontes, W. R., de Oliveira, M. L., Bader, M., Alenina, N., Moraes, M. F., Dos Santos, R. A. and Pereira, G. S. (2012) Angiotensin-(1-7)/Mas axis integrity is required for the expression of object recognition memory. Neurobiol. Learn. Mem. 97, 113-123
128. Yang, R. F., Yin, J. X., Li, Y. L., Zimmerman, M. C. and Schultz, H. D. (2011) Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am. J. Physiol. Cell. Physiol. 300, C58-C64
129. Hellner, K., Walther, T., Schubert, M. and Albrecht, D. (2005) Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol. Cell. Neurosci. 29, 427-435
130. Albrecht, D. (2007) Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO. Learn. Mem. 14, 177-184
131. Zhang, Y., Lu, J., Shi, J., Lin, X., Dong, J., Zhang, S., Liu, Y. and Tong, Q. (2008) Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 42, 593-600
132. Feng, Y., Xia, H., Cai, Y., Halabi, C. M., Becker, L. K., Santos, R. A., Speth, R. C., Sigmund, C. D. and Lazartigues, E. (2010) Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ. Res. 106, 373-382
133. Veltkamp, R., Rajapakse, N., Robins, G., Puskar, M., Shimizu, K. and Busija, D. (2002) Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 33, 2704-2710
134. Nakashima, M. N., Yamashita, K., Kataoka, Y., Yamashita, Y. S. and Niwa, M. (1995) Time course of nitric oxide synthase activity in neuronal, glial and endothelial cells of rat striatum following focal cerebral ischemia. Cell. Mol. Neurobiol. 15, 341-349
135. Moro, M. A., Cardenas, A., Hurtado, O., Leza, J. C. and Lizasoain, I. (2004) Role of nitric oxide after brain ischaemia. Cell Calcium 36, 265-275
136. Mecca, A. P., Regenhardt, R. W., O'Connor, T. E., Joseph, J. P., Raizada, M. K., Katovich, M. J. and Sumners, C. (2011) Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084-1096
137. Jiang, T., Gao, L., Guo, J., Lu, J., Wang, Y. and Zhang, Y. (2012) Suppressing inflammation by inhibiting NF-κB pathway contributes to the neuroprotection of angiotensin-(1-7) in rats with permanent cerebral ischemia. Br. J. Pharmacol. 167, 1520-1532
138. Senanayake, P., Drazba, J., Shadrach, K., Milsted, A., Rungger-Brandle, E., Nishiyama, K., Miura, S., Karnik, S., Sears, J. E. and Hollyfield, J. G. (2007) Angiotensin II and its receptor subtypes in the human retina. Invest. Ophthalmol. Visual Sci. 48, 3301-3311
139. Vaajanen, A., Lakkisto, P., Virtanen, I., Kankuri, E., Oksala, O., Vapaatalo, H. and Tikkanen, I. (2010) Angiotensin receptors in the eyes of arterial hypertensive rats. Acta Ophthalmol. 88, 431-438
140. Vaajanen, A., Vapaatalo, H., Kautiainen, H. and Oksala, O. (2008) Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye. Invest. Ophthalmol. Visual Sci. 49, 2557-2562
141. Verma, A., Shan, Z., Lei, B., Yuan, L., Liu, X., Nakagawa, T., Grant, M. B., Lewin, A. S., Hauswirth, W. W., Raizada, M. K. and Li, Q. (2012) ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy. Mol. Ther. 20, 28-36
142. Borges, E. L., Cabral, B. M., Braga, A. A., Neves, M. J., Santos, R. A. and Rogana, E. (2002) Effect of angiotensin-(1-7) on jejunal absorption of water in rats. Peptides 23, 51-56
143. Durik, M., Seva Pessoa, B. and Roks, A. J. (2012) The renin-angiotensin system, bone marrow and progenitor cells. Clin. Sci. 123, 205-223
144. Baykan, H., Gunay, G. K., Ozyazgan, I. and Soyuer, I. (2012) The effect of angiotensin (1-7) on survival of random pattern skin flaps with nicotine-induced ischemia in rats. Ann. Plast. Surg. 68, 88-93
145. Brzozowski, T., Ptak-Belowska, A., Kwiecien, S., Krzysiek-Maczka, G., Strzalka, M., Drozdowicz, D., Pajdo, R., Olszanecki, R., Korbut, R., Konturek, S. J. and Pawlik, W. W. (2012) Novel concept in the mechanism of injury and protection of gastric mucosa: role of renin-angiotensin system and active metabolites of angiotensin. Curr. Med. Chem. 19, 55-62